John Miner, MD
MOHS-Micrographic Surgery · Grand Rapids, MINPI 1023008844
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $848 of the $948 with a category attached, or 89.4%. 14 manufacturers reported payments, led by Johnson & Johnson at 35.4% of the total. Reporting peaked in 2022 at $309 and has fallen 62.8% since, to $115 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in MI, where the typical reported total is $1,792.
Across 43 payments — averaging $22.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$336
- AbbVie$136
- Regeneron Healthcare Solutions, Inc.$134
- Sanofi$116
- LEO Pharma Inc.$40
- Helsinn Therapeutics (U.S.), Inc.$39
- plus $146 from 8 others
What the payments were for
- Food & beverage$84889%
- Education$10011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 13 | $336 |
| AbbVie | 6 | $136 |
| Regeneron Healthcare Solutions, Inc. | 5 | $134 |
| Sanofi | 4 | $116 |
| LEO Pharma Inc. | 2 | $40 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $39 |
| Kyowa Kirin, Inc. | 2 | $34 |
| Amgen | 2 | $30 |
| UCB, Inc. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
| Genentech USA, Inc. | 1 | $12 |
| Galderma Laboratories, L.p. | 1 | $11 |
How this compares
$948 in reported general payments places this provider in the 25th percentile of 30 mohs-micrographic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 44 | $2,566 |
| Metronidazole | 27 | $2,010 |
| Tretinoin | 15 | $1,348 |
| Gentamicin Sulfate | 35 | $1,237 |
| Cephalexin | 208 | $916 |
| Betamethasone Dipropionate | 19 | $733 |
| Doxycycline Hyclate | 28 | $712 |
| Clobetasol Propionate | 20 | $526 |
| Ampicillin Trihydrate | 11 | $316 |
| Ketoconazole | 16 | $251 |
| Triamcinolone Acetonide | 42 | $248 |
| Mupirocin | 31 | $161 |
| Ciprofloxacin Hcl | 21 | $72 |
| Finasteride | 11 | $56 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Grand Rapids
- Adam AsarchGrand Rapids$2K
- Eileen AxibalGrand Rapids$1K
- Bryan SofenRoyal Oak$35K
- David OzogDetroit$22K
- Michael WhitworthWyandotte$13K
- David ByrdRochester Hills$10K
- Ryan JonesPortage$9K
- Abraham AbdulhakDearborn$8K
- Lindsay SklarWest Bloomfield$6K
- Luke NicholasRockford$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.